Cargando…

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study

OBJECTIVE: To assess use of two web-based conversational agents, the Family Sharing Chatbot (FSC) and One Month Chatbot (OMC), by individuals with familial hypercholesterolemia (FH). METHODS: FSC and OMC were sent using an opt-out methodology to a cohort of individuals receiving a FH genetic result....

Descripción completa

Detalles Bibliográficos
Autores principales:	Walters, Nicole L., Lindsey-Mills, Zoe T., Brangan, Andrew, Savage, Sarah K., Schmidlen, Tara J., Morgan, Kelly M., Tricou, Eric P., Betts, Megan M., Jones, Laney K., Sturm, Amy C., Campbell-Salome, Gemme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles from Special issue on Communication in Genomic and Precision Medicine; Edited by Gemme Campbell-Salome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194298/ https://www.ncbi.nlm.nih.gov/pubmed/37214500 http://dx.doi.org/10.1016/j.pecinn.2023.100134

Ejemplares similares

Communication in genomic and precision medicine: Editorial – PEC Innovation
por: Campbell-Salome, Gemme
Publicado: (2023)

Applying the framework for developing and evaluating complex interventions to increase family communication about hereditary cancer
por: Cragun, Deborah L., et al.
Publicado: (2023)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
por: Jones, Laney K., et al.
Publicado: (2021)

Barriers to family history collection among Spanish-speaking primary care patients: a BRIDGE qualitative study
por: Liebermann, Erica, et al.
Publicado: (2022)

Patient experiences align with the familial hypercholesterolemia global call to action
por: Jones, Laney K., et al.
Publicado: (2022)

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2023)

Investigation of interest in and timing preference for cancer predisposition testing and expanded carrier screening among women of reproductive age
por: Zhong, Lingzi, et al.
Publicado: (2023)

Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis
por: Ahsan, Muhammad Danyal, et al.
Publicado: (2023)

Development of a novel measure of advanced cancer patients’ perceived utility of secondary germline findings from tumor genomic profiling
por: Hamilton, Jada G., et al.
Publicado: (2023)

Delirium education for family caregivers of patients in the intensive care unit: A pilot study
por: Wheeler, Amanda, et al.
Publicado: (2023)

Development of a storytelling communication facilitation tool (SCFT) to facilitate discussion of complex genetic diagnoses between parents and their children: A pilot study using 22q11.2 deletion syndrome as a model condition
por: Bogatan, Simina, et al.
Publicado: (2022)

“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy
por: Head, Katharine J., et al.
Publicado: (2022)

Evaluation of an educational conference for persons affected by hereditary frontotemporal degeneration and amyotrophic lateral sclerosis
por: Dratch, Laynie, et al.
Publicado: (2022)

Navigating the uncertainty of precision cancer screening: The role of shared decision-making
por: Gallagher, Joseph H., et al.
Publicado: (2023)

A randomized controlled trial of analogue pharmacogenomic testing feedback for psychotropic medications
por: Young, John, et al.
Publicado: (2022)

Genetic counselling resources in non-english languages: A scoping review
por: Beauchesne, Rhea, et al.
Publicado: (2023)

Developing a question prompt list for family caregivers concerning the progression and palliative care needs of nursing home residents living with dementia
por: Thompson, Genevieve N., et al.
Publicado: (2023)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
por: Jones, Laney K., et al.
Publicado: (2022)

Cascade Screening for Familial Hypercholesterolemia (FH)
por: Ned, Renée M., et al.
Publicado: (2011)

Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
por: Campbell-Salome, Gemme, et al.
Publicado: (2022)

256 Addressing the Underdiagnosis of Familial Hypercholesterolemia
por: Kalia, Isha, et al.
Publicado: (2023)

Applying implementation science to improve care for familial hypercholesterolemia
por: Jones, Laney K., et al.
Publicado: (2022)

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
por: Jones, Laney K., et al.
Publicado: (2023)

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2021)

Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry
por: Vaseghi, Golnaz, et al.
Publicado: (2021)

Cancer caregivers at the end-of-life: How much me vs. how much we?
por: Bybee, Sara, et al.
Publicado: (2023)

A mixed-methods evaluation of the impacts of an online Carer wellbeing and connection program
por: Coe, Amy, et al.
Publicado: (2023)

An online intervention to improve the health and well-being of informal caregivers of individuals with Alzheimer's disease: A pilot study
por: Liu, Yujun, et al.
Publicado: (2023)

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
por: Walzer, S, et al.
Publicado: (2013)

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
por: Fairoozy, R. H., et al.
Publicado: (2017)

The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry
por: Alallaf, Faisal, et al.
Publicado: (2017)

Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan
por: Mabuchi, Hiroshi
Publicado: (2017)

Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FH(Marburg) (FH p.W556R)
por: Schaefer, Juergen R., et al.
Publicado: (2012)

FH ALERT: efficacy of a novel approach to identify patients with familial hypercholesterolemia
por: Fath, Felix, et al.
Publicado: (2021)

Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
por: Reddy, Lakshmi Lavanya, et al.
Publicado: (2022)

The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results
por: Al-Rasadi, Khalid, et al.
Publicado: (2020)

Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry
por: Alhabib, Khalid F., et al.
Publicado: (2021)

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
por: Jones, Laney K., et al.
Publicado: (2020)

Current Status of Familial Hypercholesterolemia in China: A Need for Patient FH Registry Systems
por: Chen, Peipei, et al.
Publicado: (2019)

GENetic characteristics and REsponse to lipid-lowering therapy in familial hypercholesterolemia: GENRE-FH study
por: Kim, Hyoeun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bumf2kur6cdkh8pbu4qcnhal2k